129 related articles for article (PubMed ID: 15934883)
1. [Cutting edge of diagnosis and treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) based on the EAN/PNS guideline 2021].
Kuwabara S
Rinsho Shinkeigaku; 2024 May; 64(5):321-325. PubMed ID: 38644208
[TBL] [Abstract][Full Text] [Related]
2. Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants.
De Lorenzo A; Liberatore G; Doneddu PE; Manganelli F; Cocito D; Briani C; Fazio R; Mazzeo A; Schenone A; Di Stefano V; Cosentino G; Marfia GA; Benedetti L; Carpo M; Filosto M; Antonini G; Clerici AM; Luigetti M; Matà S; Rosso T; Lucchetta M; Siciliano G; Lauria Pinter G; Cavaletti G; Inghilleri M; Cantisani T; Notturno F; Ricciardi D; Habetswallner F; Spina E; Peci E; Salvalaggio A; Falzone Y; Strano C; Gentile L; Vegezzi E; Mataluni G; Cotti Piccinelli S; Leonardi L; Romano A; Nobile-Orazio E;
Eur J Neurol; 2024 Apr; 31(4):e16190. PubMed ID: 38165011
[TBL] [Abstract][Full Text] [Related]
3. [Typical CIDP: Update of the Pathogenesis, Diagnosis, and Treatment].
Kuwabara S
Brain Nerve; 2024 May; 76(5):515-519. PubMed ID: 38741490
[TBL] [Abstract][Full Text] [Related]
4. [CIDP Variants].
Kokubun N
Brain Nerve; 2024 May; 76(5):520-525. PubMed ID: 38741491
[TBL] [Abstract][Full Text] [Related]
5. Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy.
Luigetti M; Primiano G; Basile V; Vitali F; Pignalosa S; Romano A; Sabino A; Marino M; Di Santo R; Ciasca G; Basile U
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279256
[TBL] [Abstract][Full Text] [Related]
6. [Management of chronic inflammatory demyelinating polyradiculoneuropathy].
Loser V; Staedler K; Sukockiené E; Uginet M; Du Pasquier R; Lalive PH; Théaudin M
Rev Med Suisse; 2024 Apr; 20(871):833-836. PubMed ID: 38665103
[TBL] [Abstract][Full Text] [Related]
7. Anti-neurofascin 155 Antibody-positive Neuropathy in a Human Immunodeficiency Virus-infected Patient.
Okubo S; Mano T; Sudo A; Goto R; Yano S; Hara M; Ishiura H; Satake W; Yanagimoto S; Ogata H; Toda T
Intern Med; 2024 Feb; 63(4):565-569. PubMed ID: 37380455
[TBL] [Abstract][Full Text] [Related]
8. Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review.
Cutellè C; De Lorenzo A; Doneddu PE; Creta MF; Selmi C; Liberatore G; Giordano A; Gentile F; Erre GL; Nobile-Orazio E
J Peripher Nerv Syst; 2024 Apr; ():. PubMed ID: 38600685
[TBL] [Abstract][Full Text] [Related]
9. Identification of rare variants in the FBXO38 gene of patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Pegat A; Chanson JB; Lozeron P; Joubert B; Bani-Sadr A; Quadrio I; Vidoni L; Latour P
J Neuroimmunol; 2024 May; 392():578381. PubMed ID: 38823119
[TBL] [Abstract][Full Text] [Related]
10. Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies.
Doneddu PE; Cocito D; Fazio R; Benedetti L; Peci E; Liberatore G; Falzone YM; Germano F; Gallia F; Giannotta C; Lleixà C; Bianchi E; Nobile-Orazio E
J Neurol Neurosurg Psychiatry; 2024 May; ():. PubMed ID: 38729746
[TBL] [Abstract][Full Text] [Related]
11. CIDP trials and tribulations.
Rinaldi S
J Neurol Neurosurg Psychiatry; 2024 May; ():. PubMed ID: 38729745
[No Abstract] [Full Text] [Related]
12. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
[TBL] [Abstract][Full Text] [Related]
13. Challenges in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Guimarães-Costa R; Iancu Ferfoglia R; Viala K; Léger JM
Rev Neurol (Paris); 2014 Oct; 170(10):595-601. PubMed ID: 25200479
[TBL] [Abstract][Full Text] [Related]
14. [Recent topics of chronic inflammatory demyelinating polyneuropathy].
Iijima M
Rinsho Shinkeigaku; 2012; 52(11):917-9. PubMed ID: 23196467
[TBL] [Abstract][Full Text] [Related]
15. Research criteria for defining patients with CIDP.
Sander HW; Latov N
Neurology; 2003 Apr; 60(8 Suppl 3):S8-15. PubMed ID: 12707417
[TBL] [Abstract][Full Text] [Related]
16. [Chronic inflammatory demyelinating polyradiculoneuropathy: clinical heterogeneity and therapeutic perspectives].
Leger JM; Bombelli F; Tran-Thanh H; Chassande B; Maisonobe T; Viala K
Bull Acad Natl Med; 2010; 194(4-5):753-64; discussion 764-5. PubMed ID: 21568049
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
Nobile-Orazio E
J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
[TBL] [Abstract][Full Text] [Related]
18. A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy.
Léger JM
Expert Opin Pharmacother; 2005 Apr; 6(4):569-82. PubMed ID: 15934883
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
